Tom Huizer

490 total citations
25 papers, 387 citations indexed

About

Tom Huizer is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Tom Huizer has authored 25 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 9 papers in Pathology and Forensic Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Tom Huizer's work include Cardiac Ischemia and Reperfusion (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Cardiac Imaging and Diagnostics (7 papers). Tom Huizer is often cited by papers focused on Cardiac Ischemia and Reperfusion (8 papers), Cardiac electrophysiology and arrhythmias (8 papers) and Cardiac Imaging and Diagnostics (7 papers). Tom Huizer collaborates with scholars based in Netherlands, Israel and Poland. Tom Huizer's co-authors include Jan Willem de Jong, A. Koos Slob, J. J. van der Werff ten Bosch, Peter van der Meer, Egbert Bos, Jan G.P. Tijssen, Peter W. Achterberg, J DEJONG, Elisabeth Keijzer and Ryszard T. Smoleński and has published in prestigious journals such as Circulation Research, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Tom Huizer

20 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Huizer Netherlands 10 153 138 116 68 58 25 387
W T Woods United States 15 47 0.3× 320 2.3× 165 1.4× 161 2.4× 37 0.6× 30 697
Tijl De Celle Netherlands 4 48 0.3× 131 0.9× 103 0.9× 8 0.1× 53 0.9× 5 366
Geoffrey N. Morris United States 12 43 0.3× 51 0.4× 133 1.1× 5 0.1× 27 0.5× 28 456
Martín Donato Argentina 15 382 2.5× 213 1.5× 141 1.2× 8 0.1× 38 0.7× 51 673
Amal Mukherjee United States 10 27 0.2× 113 0.8× 164 1.4× 5 0.1× 84 1.4× 12 403
Yukiko Yasuoka Japan 12 57 0.4× 32 0.2× 167 1.4× 44 0.6× 4 0.1× 29 361
Cees D. J. de Langen Netherlands 18 80 0.5× 677 4.9× 298 2.6× 6 0.1× 24 0.4× 35 960
Tomoko Nawata Japan 12 36 0.2× 109 0.8× 192 1.7× 57 0.8× 16 0.3× 20 445
R Detar United States 11 55 0.4× 132 1.0× 73 0.6× 16 0.2× 58 1.0× 15 408
Pfeffer Ma United States 7 36 0.2× 290 2.1× 78 0.7× 5 0.1× 38 0.7× 19 396

Countries citing papers authored by Tom Huizer

Since Specialization
Citations

This map shows the geographic impact of Tom Huizer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Huizer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Huizer more than expected).

Fields of papers citing papers by Tom Huizer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Huizer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Huizer. The network helps show where Tom Huizer may publish in the future.

Co-authorship network of co-authors of Tom Huizer

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Huizer. A scholar is included among the top collaborators of Tom Huizer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Huizer. Tom Huizer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arad, Michael, Jan Willem de Jong, Róbert de Jonge, Tom Huizer, & Babeth Rabinowitz. (1996). Preconditioning in Globally Ischemic Isolated Rat Hearts: Effect on Function and Metabolic Indices of Myocardial Damage. Journal of Molecular and Cellular Cardiology. 28(12). 2479–2490. 11 indexed citations
2.
Smoleński, Ryszard T., Jan Willem de Jong, D. Richard Lachno, et al.. (1993). Formation and Breakdown of Uridine in Ischemic Hearts of Rats and Humans. Journal of Molecular and Cellular Cardiology. 25(1). 67–74. 30 indexed citations
3.
Jong, Jan Willem de, et al.. (1993). Absence of beneficial effect of intravenous metoprolol given during angioplasty in patients with single-vessel coronary artery disease. Cardiovascular Drugs and Therapy. 7(4). 677–682. 1 indexed citations
4.
Huizer, Tom, Pieter F. van der Meer, & Jan Willem de Jong. (1992). Captopril inhibits angiotensin I-induced coronary flow reduction in isolated rat heart but has no effect on contractility or energy metabolism. European Heart Journal. 13(1). 109–114. 8 indexed citations
5.
Scheerder, Ivan K. De, et al.. (1992). Cardiac ATP breakdown and mechanical function during recurrent periods of anoxia.. PubMed. 3(3). 189–95. 5 indexed citations
6.
Huizer, Tom, et al.. (1991). Does xanthine oxidase cause damage during myocardial ischemia?. PubMed. 92(1). 41–7. 4 indexed citations
7.
Huizer, Tom. (1991). Myocardial ATP catabolism and its pharmacological prevention. RePub (Erasmus University Rotterdam). 3 indexed citations
8.
Bonnier, J. J. R. M., et al.. (1990). Myocardial protection by intravenous diltiazem during angioplasty of single-vessel coronary artery disease. The American Journal of Cardiology. 66(2). 145–150. 14 indexed citations
9.
DEJONG, J, et al.. (1990). Ischemic nucleotide breakdown increases during cardiac development due to drop in adenosine anabolism/catabolism ratio. Journal of Molecular and Cellular Cardiology. 22(10). 1065–1070. 20 indexed citations
10.
Jong, Jan Willem de, et al.. (1990). Xanthine oxidoreductase activity in perfused hearts of various species, including humans.. Circulation Research. 67(3). 770–773. 91 indexed citations
11.
Jong, Jan Willem de, et al.. (1989). Apparent inosine uptake by the human heart. Cardiovascular Research. 23(6). 484–488. 6 indexed citations
12.
Huizer, Tom. (1989). Urate production by human heart during angioplasty. Journal of Molecular and Cellular Cardiology. 21. S40–S40. 1 indexed citations
13.
Vemuri, Ramesh, et al.. (1989). Studies on oxygen and extracellular fluid restrictions in cultured heart cells: high energy phosphate metabolism. Cardiovascular Research. 23(3). 254–261. 9 indexed citations
14.
Huizer, Tom. (1989). Urate production by human heart. Journal of Molecular and Cellular Cardiology. 21(7). 691–695. 48 indexed citations
15.
Pop, Gheorghe, Patrick W. Serruys, Federico Piscione, et al.. (1987). Regional cardioprotection by subselective intracoronary nifedipine is not due to enhanced collateral flow during coronary angioplasty. International Journal of Cardiology. 16(1). 27–41. 8 indexed citations
16.
Huizer, Tom, Jan Willem de Jong, & Peter W. Achterberg. (1987). Protection by Bepridil Against Myocardial ATP-Catabolism Is Probably Due to Negative Inotropy. Journal of Cardiovascular Pharmacology. 10(1). 55–61. 18 indexed citations
17.
DEJONG, J & Tom Huizer. (1986). Dose-dependent suppression of purine production in ischemic heart by bepridil. Journal of Molecular and Cellular Cardiology. 18. 127–127. 1 indexed citations
18.
Jong, Jan Willem de & Tom Huizer. (1985). Reduced Glycolysis by Nisoldipine Treatment of Ischemic Heart. Journal of Cardiovascular Pharmacology. 7(3). 497–500. 19 indexed citations
19.
DEJONG, J, et al.. (1985). Adenine nucleotide catabolism in ischemic heart prevented by the calcium antagonist nisoldipine. Journal of Molecular and Cellular Cardiology. 17. 22–22. 1 indexed citations
20.
Jong, Jan Willem de, Tom Huizer, & Jan G.P. Tijssen. (1984). Energy conservation by nisoldipine in ischaemic heart. British Journal of Pharmacology. 83(4). 943–949. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026